A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid
Open Access
- 30 June 2005
- journal article
- conference paper
- Published by Elsevier BV in Journal of Hepatology
- Vol. 42 (6), 897-906
- https://doi.org/10.1016/j.jhep.2005.01.026
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Inhibition of the E2F‐1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid β‐peptide‐induced apoptosis of PC12 CellsJournal of Neurochemistry, 2004
- The Bile Acid Tauroursodeoxycholic Acid Modulates Phosphorylation and Translocation of Bad via Phosphatidylinositol 3-Kinase in Glutamate-Induced Apoptosis of Rat Cortical NeuronsThe Journal of pharmacology and experimental therapeutics, 2004
- Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathwaysHepatology, 2004
- Ursodeoxycholic Acid Modulates E2F-1 and p53 Expression through a Caspase-independent Mechanism in Transforming Growth Factor β1-induced Apoptosis of Rat HepatocytesPublished by Elsevier BV ,2003
- Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: An observational studyHepatology, 2003
- Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory PathwayScience, 2003
- Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress–induced caspase-12 activationHepatology, 2002
- Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formationCell Death & Differentiation, 1999
- A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.JCI Insight, 1998
- HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family.Genes & Development, 1997